Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase

Ricardo Cambraia Parreira1,2,3, Diana Paola Gómez-Mendoza1, Itamar Couto Guedes de Jesus1

  • 1Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil.

Insights

This study reveals molecular changes in early cardiac hypertrophy using proteomic analysis. Identified markers like MYH7 may aid in early diagnosis of heart failure.

Area of Science:

  • Cardiovascular Biology
  • Proteomics
  • Molecular Cardiology

Background:

  • Cardiac hypertrophy is a significant risk factor for heart failure.
  • Early molecular events in compensated cardiac hypertrophy remain incompletely understood.

Purpose of the Study:

  • To comprehensively characterize molecular events in early compensated cardiac hypertrophy at the cardiomyocyte level.
  • To identify potential early diagnostic markers for cardiac hypertrophy.

Main Methods:

  • Quantitative label-free proteomic analysis of cardiomyocytes.
  • Isoproterenol (ISO) treatment in mice to induce hypertrophy.
  • Canonical pathway analysis and confocal microscopy.

Main Results:

  • Isoproterenol-induced hypertrophy activates actin cytoskeleton and integrin-linked kinase (ILK) signaling, while inhibiting sirtuin signaling.
  • Upregulation of myosin-7 (MYH7) impacts cardiac contractile and calcium signaling.
  • Identified potential early markers: APBB1, GOLGA4, HOOK1, KATNA1, KIFBP, MAN2B2, and SLC16A1.

Conclusions:

  • Provides a molecular map of ISO-induced compensated cardiac hypertrophy in cardiomyocytes.
  • Identified marker candidates may facilitate early diagnosis and intervention for cardiac hypertrophy and heart failure.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
263
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
575
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
16.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
261